Contract - Global Supply Planner at Cytokinetics

Dublin, County Dublin, Ireland

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceutical, CardiovascularIndustries

Requirements

Bachelor’s degree in Supply Chain Management, Pharmaceutical Sciences, Business Administration, or a related field
7–10 years of experience in pharmaceutical supply chain or related planning functions
Strong understanding of pharmaceutical production processes, inventory management, and regulatory requirements (GxP, FDA, EMA)
Experience with supply chain systems and planning tools (e.g., ERP, forecasting software)
Excellent analytical, problem-solving, and data-driven decision-making skills
Strong communication and interpersonal skills with the ability to work effectively across cross-functional teams
Prior experience in the pharmaceutical or life sciences industry with exposure to global supply chain operations

Responsibilities

Support the development and maintenance of global supply plans, ensuring alignment with business requirements, regulatory standards, and market needs
Help optimize inventory strategies and E2E supply chain configurations by maintaining accurate planning parameters and identifying potential risks
Execute planning activities in compliance with pharmaceutical regulations and internal SOPs
Prepare data, analyses, and scenario models to support the S&OP process
Collaborate with cross-functional partners to review demand, supply, and inventory positions and highlight potential imbalances
Assist in resolving supply disruptions, capacity constraints, and forecast discrepancies by providing analysis and recommendations
Contribute to the creation of supply plans used for annual budget processes, including capacity, inventory, and purchasing inputs
Track and report operational KPIs such as service levels, inventory levels, on-time delivery performance, and forecast accuracy
Support the balance of short-term operational needs with longer-term planning considerations
Partner with teams including regulatory affairs, quality, commercial, finance, external manufacturing, and logistics to ensure alignment of supply plans
Provide planning insights to internal stakeholders and ensure coordinated execution of supply chain activities
Work with regional and local teams to support regulatory- and market-specific requirements
Participate in initiatives to streamline planning processes and enhance operational efficiency
Monitor industry trends, technologies, and regulatory updates relevant to supply planning
Support implementation of planning system enhancements and best practices

Skills

Supply Planning

S&OP

Demand Planning

Inventory Management

Supply Chain

Pharmaceutical Regulations

SOPs

Scenario Modeling

Risk Identification

Cross-Functional Collaboration

Cytokinetics

Develops drugs for muscle function disorders

About Cytokinetics

Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a pipeline of drugs, including omecamtiv mecarbil and reldesemtiv, which are in various stages of clinical trials. Unlike many competitors, Cytokinetics emphasizes rigorous scientific research and has conducted over 50 clinical trials to ensure the effectiveness of its treatments. The goal is to bring new therapies to market that address the unmet needs of patients suffering from conditions like heart failure, ALS, and HCM.

South San Francisco, CaliforniaHeadquarters

1998Year Founded

$58.4MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Risks

Increased competition could impact market share and profitability.

Potential delays in clinical trials could hinder drug commercialization.

Dependence on strategic partnerships may expose Cytokinetics to risks if challenges arise.

Differentiation

Cytokinetics focuses on muscle activators and inhibitors for cardiovascular and neuromuscular diseases.

The company has a robust pipeline including omecamtiv mecarbil and aficamten.

Cytokinetics engages in strategic partnerships, like with Sanofi, to expand market reach.

Upsides

Recent investments indicate strong interest in muscle activators and inhibitors.

Strategic partnerships, like with Sanofi, expand market reach and potential revenue.

Significant funding from Royalty Pharma supports commercial launch and R&D advancements.

Land your dream remote job 3x faster with AI

Try Jobo Free